About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision‑making by clinicians, managers, and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
This briefing was developed for NICE by the Birmingham and Brunel Consortium. The interim process and methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality assured and approved for publication.
Zulian Liu, Research Fellow, Birmingham and Brunel Consortium, University of Birmingham
Rui Duarte, Research Fellow, Birmingham and Brunel Consortium, University of Birmingham
Catherine Meads, Deputy Director, Birmingham and Brunel Consortium, Brunel University
Laura Norburn, Public Involvement Adviser, Public Involvement Programme, National Institute for Health and Care Excellence
The following specialist commentators provided comments on a draft of this briefing:
John Moore, Consultant in Anaesthetics and Intensive Care Medicine, Central Manchester University Hospitals NHS Foundation Trust
Sandeep Dhir, Consultant in Intensive Care Medicine and Anaesthesia, Sherwood Forest Hospitals NHS Foundation Trust
Duncan Wyncoll, Intensive Care Unit Consultant, Guy's and St Thomas' NHS Trust
© National Institute for Health and Care Excellence 2015. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not‑for‑profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.